Dr. Ramin Artang, F.A.C.C., a cardiologist at Mercy Heart Center in Sioux City, was a recent presenter at the annual conference of the American College of Cardiology in Chicago. Dr. Artang was the principal investigator for a study entitled: Dabigatran and Myocardial Infarction, Drug or Class Effect: Meta-Analysis of Randomized Trials with Oral Direct Thrombin Inhibitors.
The study was done in collaboration with Dr. Artang’s colleagues at the University of Nebraska Medical Center in Omaha and the University of Wisconsin. Investigators looked at all published clinical trials with more than 30 thousand patients that applied new blood thinners in the class known as direct thrombin inhibitors and compared it to the well known blood thinner warfarin – commonly known as Coumadin.
In recent years several new blood thinners have been introduced as alternatives to Coumadin – a drug that has been in use in the United States since 1954. Although warfarin is a well known and frequently used drug, many physicians and patients have identified a number of challenges with its use one of which is the need for frequent blood draws making it inconvenient for patients.
The new class of drugs such as dabigatran (Pradaxa®) and rivaroxaban (Xarelto®) offer the advantage that no blood draws are needed like the majority of the other medications people use such as aspirin. This advantage seems favorable for many patients and their doctors. Patients who particularly benefit from these agents are those who had difficulties staying in the therapeutic range on warfarin.
Dr. Artang is a familiar name when it comes to cardiac care in Siouxland. After serving as an assistant professor of medicine and cardiac imaging at the University of Nebraska Medical Center, Dr. Artang returned to Sioux City to join the staff at Mercy Cardiology. He is board certified in internal medicine, echocardiography, nuclear cardiology and cardiac CT.
For more information, contact:
Jim Wharton, Vice President of Marketing and Business Development (712) 279-2732
Dianne Krier, Mercy Marketing and Communications Coordinator (712) 279-5682